A multinational, multicentre, single blood sampling exploratory pharmacogenetic study of the REGARD (the REbif vs Glatiramer Acetate in Relapsign MS Disease) trial

Hdl Handle:
http://hdl.handle.net/10147/140695
Title:
A multinational, multicentre, single blood sampling exploratory pharmacogenetic study of the REGARD (the REbif vs Glatiramer Acetate in Relapsign MS Disease) trial
Issue Date:
25-Aug-2011
URI:
http://hdl.handle.net/10147/140695
Ethical Approval:
Yes

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-08-25T10:12:25Z-
dc.date.available2011-08-25T10:12:25Z-
dc.date.issued2011-08-25T10:12:25Z-
dc.identifier.urihttp://hdl.handle.net/10147/140695-
dc.titleA multinational, multicentre, single blood sampling exploratory pharmacogenetic study of the REGARD (the REbif vs Glatiramer Acetate in Relapsign MS Disease) trialen
dc.type.qualificationlevelN/Aen
cr.approval.ethicalYesen
dc.description.provinceLeinster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.